Morphological Features of Bronchiectasis in Patients With Non-tuberculous Mycobacteriosis and Interstitial Pneumonia

doi:10.21203/rs.3.rs-1432960/v1

Background: The pathogenesis of bronchiectasis differs between chronic lower respiratory tract infection and interstitial pneumonia. However, there has been no report that compared their morphological characteristics by quantitative analysis of high-resolution computed tomography (HRCT) images.

Objective: We aimed to compare the morphological features of bronchiectasis between patients with different underlying diseases.

Method: Fourteen patients with non-tuberculous mycobacteriosis (NTM) and 13 with idiopathic pulmonary fibrosis (IPF) were included. A 3D image of the bronchial structure was made from HRCT data using Ziostation 2 (Ziosoft, Inc., Tokyo, Japan). Bronchiectasis was defined as abnormal dilatation of the bronchi with the diameter greater than that of the accompanying pulmonary artery. We measured the inner and outer diameters, wall area as %total airway cross sectional area (WA%), and wall thickness to airway diameter ratio (T/D) of the 4-8th generations of bronchi.

Result: In patients with IPF, the inner and outer diameters linearly decreased toward the distal bronchi. In contrast, the inner and outer diameters of NTM fluctuated. The coefficient of variation of the outer diameters of the 6-7th generations of bronchi was larger in the NTM patients than in those with IPF, whereas no significant difference was observed in the coefficient of variation of the inner diameters between the groups. In IPF patients, WA% and T/D varied between the generation of bronchi, but the coefficient of variation of WA% and T/D was relatively small in those with NTM.

Conclusion: The morphological characteristics of bronchiectasis were different between the IPF patients and those with NTM, which might be associated with the pathogenesis of bronchiectasis and edematous changes of the bronchial walls.

Bronchiectasis is a progressive respiratory disease characterized by irreversible and pathological dilatation of the small- and medium-sized bronchi [1]. In recent years, the prevalence of bronchiectasis has increased due to the aging of the population and the widespread use of high-resolution computed tomography (HRCT), and the high morbidity and mortality rates have made it a worldwide problem [2].

The etiology of bronchiectasis can be divided into two patterns. One is mainly caused by chronic or recurrent infections or other chronic airway inflammation, which causes loss of smooth muscle and elastic, leading to airway remodeling [3, 4]. Mycobacterium avium complex (MAC) and other non-tuberculous mycobacteria are known to be the major etiologic organisms of bronchiectasis and account for a large proportion of cases in Japan [5]. The other is traction bronchiectasis, which is caused by collapse of the surrounding alveoli due to inflammation or fibrosis. Traction bronchiectasis refers to the irreversible dilatation of the bronchi and is known as an important feature of fibrotic lung disease [6]. Thus, bronchiectasis has different origins and pathological findings depending on the etiology, but little is known about the morphological features of bronchiectasis of different etiologies.

In 1980’s, computed tomography (CT) is applied to diagnosis of bronchiectasis with sensitivities of 60–100% and specificities of 92–100% [7]. Recent advances in imaging technology, such as thickness and interval of sclices, improved the diagnostic accuracy, and HRCT is the standard tool of the diagnosis of bronchiectasis [1]. However, no report has quantitatively evaluated the morphological differences between bronchiectasis due to airway remodeling and traction bronchiectasis using imaging data.

In the present study, we aimed to quantitatively compare the morphological characteristics between bronchiectasis due to nontuberculous mycobacteriosis (NTM) and traction bronchiectasis associated with idiopathic pulmonary fibrosis (IPF) by using CT workstation and 3D-images of HRCT.

Study subjects

This is a retrospective observational study and its protocol was approved by the Ethics Committee of Hirosaki University Graduate School of Medicine (approval number: 2019 − 1043). Written informed consent was waived because of the retrospective design of the study. We evaluated consecutive patients who were treated for NTM or IPF between January 2014 and December 2018. The diagnosis of NTM lung disease was made by the ATS/IDSA diagnostic criteria published in 2007 [8]. For the diagnosis of IPF, the 2018 updated guideline was used [9]. Patients who did not undergo HRCT with a slice thickness of 1.0 mm or less and those who had no findings of bronchiectasis were excluded.

Morphological analysis

We evaluated the HRCT images using a CT-3D imaging workstation (Ziostation2^®, Ziosoft, Tokyo, Japan). On HRCT, bronchiectasis was defined as abnormal dilatation of the bronchi with the diameter greater than that of the accompanying pulmonary artery [10]. We measured the inner and outer diameters, wall area as %total airway cross sectional area (WA%), and wall thickness to airway diameter ratio (T/D) of the 4th-8th generations of bronchi [11].

As for the measurement procedure, we first constructed 3D images from the captured HRCT images and selected a bronchus to be measured. The path from the trachea to the target bronchus was automatically extracted. In cases the lung structure was highly deformed and automatic extraction by the application was difficult, manual plots from the trachea to bronchus were performed (Fig. 1). Once the bronchi are extracted, the bronchial cross section at the specified position is displayed and the inner and outer diameters are marked. Once the marking was confirmed, the inner and outer diameters, WA%, and T/D ratio were automatically calculated for the 4th-8th generations of bronchi. Since intrapulmonary structures were distinguished by CT values, manual corrections were made when there was a large discrepancy between the outer and inner wall markings. Three points were measured for each generation of bronchial tubes, and the average of these points was used to calculate the value. When the distance to the branch of the bronchus was too short to obtain three measurement points, one or two points were measured and the average was calculated.

Statistics

Data were presented as means and standard deviations, and the coefficient of variation was calculated by dividing the standard deviation by the mean value. Statistical analyses were performed using JMP 15 (SAS Institute, Cary, NC, USA).

Patient characteristics

A total 27 patients, 14 with NTM and 13 with IPF, were included in this study. All of the IPF patients were diagnosed solely with HRCT that revealed a usual interstitial pneumonia (UIP) pattern in 12 patients and a probable UIP pattern in one. None of the study subjects underwent lung biopsy.

There was no significant difference in age between the patients with NTM and those with IPF. In terms of gender, there were more females in the NTM group and more males in the IPF group. Most of the IPF patients were smokers. The lung function data were available only for the IPF patients, which showed decreases in FVC, %FVC, and %DL_CO, suggesting that many patients with moderate or severe IPF were included (Table 1).

Table 1

Patients Characteristics
	NTM (n = 14)	IPF (n = 13)
Age (years)	76.2 ± 6.7	68.9 ± 8.1
Male/Female	3/11	10/3
Smoking status (+/-)	2/12	12/1
FVC (mL)	-	1901.1 ± 532.1
%FVC (%)	-	58.1 ± 14.6
%DLCO (%)	-	46.9 ± 18.1
FVC: forced vital capacity, DLCO: diffusing capacity for carbon monoxide.
Data are presented as mean ± standard deviation.

Morphological parameters

The morphological parameters of bronchiectasis evaluated in this study were summarized in Fig. 2. Line graphs were made for four items: inner diameter, outer diameter, WA%, and T/D ratio. The graphs were created by calculating the ratios of the measurements for the 5th to 8th generations of bronchi, using the 4th generation bronchi as a reference.

In the patients with IPF, the outer and inner diameters decreased linearly toward the distal part of the bronchus (Fig. 2A and 2B). In contrast, in the NTM patients, some bronchi were larger at the distal part, and the outer and inner diameter measurements of a generation of the bronchi were largely different between the patients.

Contrary to the results for outer and inner diameter, WA% and T/D ratio in most of the NTM patients increased linearly toward the distal part of the bronchus although the values were diverse between the subjects (Fig. 2C and 2D). In the patients with IPF, larger values of WA% and T/D ratio were observed at the distal part.

Coefficient of variation of the morphological parameters

Since the results of the line graph showed that there was a large variation in the measurements between the 5th and 7th generations of the bronchi, the coefficient of variation was calculated (Table 2). In the 6th to 7th generations of the bronchi, the coefficient of variation of the outer diameter was larger in the NTM patients than in those with IPF. The coefficients of variation of the inner diameter were similar in the NTM and IPF patients. The coefficients of variations of WA% and T/D were relatively small in the NTM patients, compared to those in the IPF patients.

Table 2

Coefficient of variation
	Generation of bronchi	NTM (n = 14)	IPF (n = 13)
Outer Diameters	6th	0.1908	0.1656
Outer Diameters	7th	0.2005	0.1441
Inner Diameters	6th	0.2377	0.2213
Inner Diameters	7th	0.2443	0.2256
WA%	6th	0.0799	0.0909
WA%	7th	0.0700	0.1145
T/D ratio	6th	0.1067	0.1172
T/D ratio	7th	0.0962	0.1508
WA%: wall area as % total airway cross sectional area
T/D ratio: wall thickness to airway diameter ratio.

In the presents study, morphological features of bronchiectasis were evaluated using HRCT images, comparing the patients with NTM and those with IPF. In the NTM patients, the inner diameter and outer diameter fluctuated greatly depending on the generation of the bronchus, while in the IPF patients, the inner diameter and outer diameter decreased linearly toward the distal side. In contrast, in the NTM patients, WA% and T/D ratio increased linearly toward the distal side, whereas, in the IPF patients, WA% and T/D ratio fluctuated between generations of the bronchi. In summary, the changes seen in dilated bronchi differed between NTM and IPF, with NTM having a larger lumen and thicker wall possibly due to edematous changes of the bronchial wall, and IPF having a larger lumen and thinner airway wall due to traction along with the fibrosis of the surrounding alveoli. (Fig. 3). To the best of our knowledge, this is the first report that evaluated morphological features of bronchiectasis using HRCT images.

Lung disease, which accounts for 80–90% of NTM, is a chronic progressive disease, causing bronchiectasis [12]. Its characteristic pathologic findings include extensive granulomas affecting the airways. Peribronchial granulomas of the trachea, bronchi, and bronchioles can cause airway narrowing, and at the same time, granulomas can disrupt the muscular layer of the airway and cause bronchiectasis [13, 14]. The increased thickness of the tracheal wall seen in NTM may also reflect ulceration of the bronchial wall and edematous changes due to infiltration of inflammatory cells into the periphery of the bronchi.

On the other hand, traction bronchiectasis is a characteristic finding in fibrotic lung diseases such as IPF. Pathologically, it is a secondary dilatation of the bronchi and bronchioles as a result of contraction of the lung tissue around the airways due to inflammation, fibrosis and scarring [7]. The presence of traction bronchiectasis in IPF has been reported to correlate with the abundance of fibroblastic foci [15], which is also a predictor of poor prognosis [16]. In addition, in the UIP pattern seen in IPF, fibrosis has been found to begin in the alveolar structures and continue from the peripheral lobular margins into the more proximal airways [17].

In this study, we observed that the IPF patients had dilated bronchi with stretched and thinned walls, which were consistent with the pathological findings. However, there was no significant difference in the coefficient of variation between the distal and proximal sides, probably because we measured bronchiectasis that had already been completed after a long period of time. If the measurements had been taken at a relatively early stage of the disease, there might have been a difference between distal and proximal bronchiectatic findings.

In the present study, we included patients with NTM as a representative of chronic lower respiratory tract infections. However, NTM is caused by intracellular organisms and pathologically characterized by granulomas, which is different from most bacterial infection [18]. It remains unclear whether the results of this study can be applicable to chronic lower respiratory tract infections caused by other pathogens, such as Haemophilus influenzae and Pseudomonas aeruginosa.

There have been a few reports about the distribution of bronchiectasis, and the spatial heterogeneity of the disease makes it difficult to reach a consensus. Reid described that, in cylindrical bronchiectasis, the average numbers of bronchial subdivisions were 7.5 on bronchogram but 16 in histopathology [19]. Recently, Ikezoe and colleagues reported that thickening of the airway wall and dilation of the lumen were observed in the 7th to 17th generation in IPF patients [20]. They also noted that the airway lumen was dilated due to the presence of markedly non-uniform strain along the bronchioles. This may be comparable with the coefficient of variation used as a measure of variability in our study.

There are several limitations to our study. Firstly, the study was conducted at only one institution and the total number of patients was small. The existence and effect of chance errors cannot be denied. Secondly, the automatic extraction of the airway by the image workstations is based on the CT values, which makes it difficult to distinguish between anatomical airway structures and transient appearance of secretions or other materials when their CT values are similar. Thirdly, we evaluated the HRCT data taken at a single time point in the patients with established bronchiectasis. Due to the lack of longitudinal data, it remains unclear whether the results of the present study can be applicable to the airways with developing bronchiectasis.

The present study indicated that the morphological features of bronchiectasis differ between NTM and IPF patients: edematous changes in the bronchial wall in NTM and tractional thinning of the bronchial wall in IPF, each condition may be reflected in the imaging findings.

CT: computed tomography; HRCT: High-resolution computed tomography; IPF: Idiopathic pulmonary fibrosis; MAC: Mycobacterium avium complex; NTM: non-tuberculous mycobacteriosis; T/D: wall thickness to airway diameter ratio; WA%: %total airway cross sectional area

Ethics approval and consent to participate

The study conformed to the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Hirosaki University Graduate School of Medicine (approval number: 2019-1043). The study was conducted in accordance with relevant code of ethics and regulations. The Ethics Committee of Hirosaki University Graduate School of Medicine waived written informed consent because of the retrospective design.

Consent for publication

Not applicable

Availability of data and materials

The datasets used and analyzed during the current study are not publicly available due to patients’ confidentiality but are available from the corresponding author on reasonable request.

Competing interests

The authors declare that they have no competing interests.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Authors’ contributions

All authors participated in the interpretation of the study results and review of the manuscript; CT designed and conducted all the measurements, drafted the manuscript, and performed the statistical analyses. ST planned the study and drafted the manuscript. MD, YI, MI, HT, and KT participated in the data collection. All authors read and approved the final manuscript.

Acknowledgements

The results of the present study were presented at European Respiratory Society International Congress 2020 in September 2020.

McShane PJ, Tino G. Bronchiectasis. Chest. 2019; 155: 825-33.
Martinez-Garcia MA, Polverino E, Aksamit T. Bronchiectasis and chronic airway disease: It is not just about asthma and COPD. Chest. 2018; 154: 737-9.
Izhakian S, Wasser WG, Fuks L, Vainshelboim B, Fox BD, Fruchter O, Kramer MR. Lobar distribution in non-cystic fibrosis bronchiectasis predicts bacteriologic pathogen treatment. Eur J Clin Microbiol Infect Dis. 2016; 35: 791-6.
McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013; 188: 647-56.
Kadowaki T, Yano S, Wakabayashi K, Kobayashi K, Ishikawa S, Kimura M, Ikeda T. An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis. Respir Investing. 2015; 53: 37-44.
Hida T, Nisino M, Hino T, Lu J, Putman RK, Gudmundsson EF, Araki T, Valtchinov VI, Honda O, Yanagawa M, Yamada Y, Hata A, Jinzaki M, Tomiyama N, Honda H, Estepar RSJ, Washko GR, Johkoh T, Christiani DC, Lynch DA, Gudnason V, Gudmundsson G, Hunninghake GM, Hatabu H. Traction bronchiectasis/bronchiolectasis is associated with interstitial lung abnormality mortality. Eur J Radiol. 2020; 129: 109073.
Stanford W, Galvin JR. The diagnosis of bronchiectasis. Clin Chest Med. 1988; 9: 691-9.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, Fordham von Reyn C, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America et al. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175:367-416.
Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DA, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018; 198: e44-e68.
Perez-Rovira A, Kuo W, Petersen J, Tiddens HA, de Bruijne M. Automatic airway-artery analysis on lung CT to quantify airway wall thickening and bronchiectasis. Med Phys. 2016; 43: 5736.
Little SA, Sproule MW, Cowan MD, Macleod KJ, Robertson M, Love JG, Chalmers GW, McSharry CP, Thomson NC. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax. 2002; 57: 247-53.
Wittram C, Weisbrod GL. Mycobacterium avium complex lung disease in immunocompetent patients: radiography–CT correlation. Br J Radiol. 2002; 75: 340-4.
Fujita J, Ohtsuki Y, Suemitsu I, Shigeto E, Yamadori I, Obayashi Y, Miyawaki H, Dobashi N, Matsushima T, Takahara J. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. Eur Respir J. 1999; 13: 535-40.
Walsh SL, Wells AU, Sverzellati N, Devaraj A, von der Thüsen J, Yousem SA, Colby TV, Nicholson AG, Hansell DM. Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease. BMC Med. 2015; 13: 241.
Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, Kondoh Y, Ogura T, Arakawa H, Fujimoto K, Inoue A, Mihara N, Honda O, Tomiyama N, Nakamura H, Müller NL. Computed tomography findings in pathological usual interstitial pneumonia: Relationship to survival. Am J Respir Crit Care Med. 2008; 177: 433-9.
Leslie KO. Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: A unifying hypothesis regarding etiology and pathogenesis. Arch Pathol Lab Med. 2012; 136: 91-600.
Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J. 2008; 31: 396-406.
Yoshida Y, Takaku Y, Nakamoto Y, Takayanagi N, Yanagisawa T, Takizawa H, Kurashima K. Changes in airway diameter and mucus plugs in patients with asthma exacerbation. PLoS One. 2020; 15: e0229238.
Reid LM. Reduction in bronchial subdivision in bronchiectasis. Thorax. 1950; 5: 233-47.
Ikezoe K, Hackett TL, Peterson S, Prins D, Hague CJ, Murphy D, LeDoux S, Chu F, Xu F, Cooper JD, Tanabe N, Ryerson CJ, Paré PD, Coxson HO, Colby TV, Hogg JC, Vasilescu DM. Small airway reduction and fibrosis is an early pathologic feature of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2021; 204: 1048-59.

No competing interests reported.

Morphological Features of Bronchiectasis in Patients With Non-tuberculous Mycobacteriosis and Interstitial Pneumonia

Archived Versions:

Version 1

Abstract

Figures

Introduction

Methods

Study subjects

Morphological analysis

Statistics

Result

Patient characteristics

Morphological parameters

Coefficient of variation of the morphological parameters

Discussion

Conclusion

Abbreviations

Declarations

References

Additional Declarations

Archived Versions:

Version 1